EGFR and non-small cell lung carcinoma: Therefore, creative basket trial designs in parallel with added knowledge from smaller case series and extrapolation from the available data in relatively larger molecular subsets of NSCLC (such as EGFR-mutant disease) will be pivotal to effectively inform clinical practice and advance viable treatment strategies.